LXR Activation Down-regulates Lipid Raft Markers FLOT2 and DHHC5 in MCF-7 Breast Cancer Cells
Delphine Carbonnelle1, Trang H Luu1, Chloe Chaillou1
1Faculty of Pharmacy, EA 2160 MMS - «Institut Universitaire Mer et Littoral», FR3473 CNRS, «Centre de Recherche en Nutrition Humaine Ouest» (CRNH Ouest), UBL Nantes University, Nantes, France.
Background/Aim:
Lipid rafts are cholesterol-enriched microdomains of the plasma membrane. Recent studies have underlined that their integrity is critical for cancer cell survival. Liver X receptor (LXR) has a central role in cellular cholesterol homeostasis and its stimulation inhibits proliferation of several cancer cell lines. This study investigated whether LXR could modulate lipid rafts integrity and consequently alter proliferation of the MCF-7 breast cancer cell line.
Materials And Methods:
Effect of LXR agonist T0901317 on integrity of MCF-7 lipid rafts was examined by studying the expression of rafts marker flotillin-2 (FLOT2) and DHHC5, which palmitoylates FLOT2, and by studying the expression of phospho-Akt.
Results:
We demonstrated that LXR stimulation decreases mRNA and protein expression of FLOT2 and DHHC5 in MCF-7 cells. LXR stimulation also reduces Akt phosphorylation and its localization at the plasma membrane.
Conclusion:
We showed, for the first time, that LXR regulates transcription of specific proteins of lipid rafts in a breast cancer model.
